Literature DB >> 21298818

PneumococcaL meningitis in french children before and after the introduction of pneumococcal conjugate vaccine.

Corinne Levy1, Emmanuelle Varon, Edouard Bingen, Aurélie Lécuyer, Michel Boucherat, Robert Cohen.   

Abstract

In France, despite a high rate of pneumococcal conjugate vaccine coverage, the number of cases of pneumococcal meningitis in children did not decline significantly between 2001–2002 (n = 264) and 2007–2008 (n = 244). A decline was observed among children < 2 years old (185 [70.1%] to 134 [54.9%] cases; P = 0.0004), but was counterbalanced by an increase among children ≥ 2 years old (79 [29.9%] to 110 [45.1%] cases). Mean age increased significantly, from 2.3 (median 0.8) to 3.8 (median 1.5) years. After pneumococcal conjugate vaccine 7 implementation, a wide diversity of serotypes implicated in pneumococcalmeningitis was observed; serotypes 19A and 7F were the most frequent.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21298818     DOI: 10.1097/inf.0b013e3181f4cf69

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  17 in total

Review 1.  Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity.

Authors:  Richard Malley; Porter W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-02       Impact factor: 11.205

Review 2.  Serotype replacement in disease after pneumococcal vaccination.

Authors:  Daniel M Weinberger; Richard Malley; Marc Lipsitch
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

Review 3.  The multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014.

Authors:  Robert Cohen; Sandra Biscardi; Corinne Levy
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

4.  Invasive pneumococcal disease in children can reveal a primary immunodeficiency.

Authors:  Jean Gaschignard; Corinne Levy; Maya Chrabieh; Bertrand Boisson; Cécile Bost-Bru; Stéphane Dauger; François Dubos; Philippe Durand; Joël Gaudelus; Dominique Gendrel; Christèle Gras Le Guen; Emmanuel Grimprel; Gaël Guyon; Catherine Jeudy; Eric Jeziorski; Francis Leclerc; Pierre-Louis Léger; Fabrice Lesage; Mathie Lorrot; Isabelle Pellier; Didier Pinquier; Loïc de Pontual; Philippe Sachs; Caroline Thomas; Pierre Tissières; Frédéric V Valla; Philippe Desprez; Véronique Frémeaux-Bacchi; Emmanuelle Varon; Xavier Bossuyt; Robert Cohen; Laurent Abel; Jean-Laurent Casanova; Anne Puel; Capucine Picard
Journal:  Clin Infect Dis       Date:  2014-04-23       Impact factor: 9.079

5.  What timing of vaccination is potentially dangerous for children younger than 2 years?

Authors:  Pauline Gras; Anne-Charlotte Bailly; Marion Lagrée; Benoit Dervaux; Alain Martinot; François Dubos
Journal:  Hum Vaccin Immunother       Date:  2016-05-24       Impact factor: 3.452

Review 6.  Acute bacterial meningitis in infants and children: epidemiology and management.

Authors:  Shruti Agrawal; Simon Nadel
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

Review 7.  Serotype-independent pneumococcal vaccines.

Authors:  Eliane Namie Miyaji; Maria Leonor Sarno Oliveira; Eneas Carvalho; Paulo Lee Ho
Journal:  Cell Mol Life Sci       Date:  2012-12-27       Impact factor: 9.261

8.  Pediatric osteoarticular infections caused by Streptococcus pneumoniae before and after the introduction of the heptavalent pneumococcal conjugate vaccine.

Authors:  C Lemaître; A Ferroni; C Doit; H Vu-Thien; C Glorion; J Raymond; P Mary; P Wicart; E Bingen; B Ilharreborde; M Lorrot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-09       Impact factor: 3.267

9.  Interaction of Vaccination and Reduction of Antibiotic Use Drives Unexpected Increase of Pneumococcal Meningitis.

Authors:  Matthieu Domenech de Cellès; Margarita Pons-Salort; Emmanuelle Varon; Marie-Anne Vibet; Caroline Ligier; Véronique Letort; Lulla Opatowski; Didier Guillemot
Journal:  Sci Rep       Date:  2015-06-11       Impact factor: 4.379

Review 10.  A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis.

Authors:  Myint Tin Tin Htar; Harish Madhava; Paul Balmer; Dina Christopoulou; Damianos Menegas; Eric Bonnet
Journal:  Adv Ther       Date:  2013-09-03       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.